Author Archive | spadmin

RSV (Respiratory Syncytial Virus) Vaccine: The US Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through […]

Continue Reading
Thursday, July 25, 2024
Copyright 2024 Smithfield Pediatrics